The Molecular Biology and Biochemistry (MBB) Core of the DDRCC provides services critical to characterizing the? fundamental building blocks of all living organisms: DNA, RNA, proteins and lipids. Alterations in these macromolecules are directly involved in dysregulations characterizing immune, inflammatory and neoplastic conditions of the Gl tract. This Core includes 4 major components: (1) DNA, (2) RNA, (3) Protein, and (4) Membrane lipid analysis. This Core replaced the Membrane Biophysics and Biochemistry Core in response to surveys of DDRCC members, who requested additional basic analytical services in each of these biomolecular areas. Several previous services, including ionized Ca2+ and immunostaining, were incorporated into other Cores. For DNA analysis, the MBB partnered with the Cancer Center equencing facility that enhanced the efficiency and cost savings and improved the technology for DNA sequencing. The Core's RNA component includes real time PCR and facilitated access to the University of Chicago's functional genomics laboratory. The DDRCC partnered with the functional genomics component, under the direction of Dr. Xininin Li, to offer this powerful technology at substantial cost savings to DDRCC members. The Core's protein component includes facilitated access to the proteomic facility and a consultative service for signal transduction studies. The DDRCC partnered with the University of Chicago proteomics laboratory that includes state of the art Mass Spectrometry resources under the direction of Dr. Alex Schilling. The DDRCC provides members substantial discounts for proteomics experiments to facilitate the wider use of this powerful technology by researchers in Gl-related disorders. The lipid composition stucies of the original Core were expanded to include membrane lipid raft preparations to assess their roles as signaling platforms. The Core's accounting functions are centralized in the administrative Core that enhances efficiency, cost-effectiveness, and coordination with these components. The Administrative Directors of the MBB Core, Drs. Marc Bissonnette and Judy Cho, oversee the operations of? all components. Directors are responsible for ensuring proper scientific direction and efficient use of services and facilities of their respective sections. Restructuring this Core to allow members to use DNA arrays and proteomic analysis at greatly reduced costs has increased the usership of these laboratories, which is anticipated to grow substantially during the next cycle of this Grant. This Core is heavily used by DDRCC members because of substantial cost savings, relevance, and high quality of services and resources. Each of the Components offers training of new and established investigators unfamiliar with these experimental approaches. The MBB Core has helped to foster multidisciplinary collaborations ard promote productive exchanges brought about by sharing of resources.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK042086-17
Application #
7596683
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
17
Fiscal Year
2007
Total Cost
$83,649
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
McIntosh, Christine M; Chen, Luqiu; Shaiber, Alon et al. (2018) Gut microbes contribute to variation in solid organ transplant outcomes in mice. Microbiome 6:96
Dugas, Lara R; Lie, Louise; Plange-Rhule, Jacob et al. (2018) Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol. BMC Public Health 18:978
Panés, Julian; Vermeire, Séverine; Lindsay, James O et al. (2018) Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis 12:145-156
Overstreet, A M; LaTorre, D L; Abernathy-Close, L et al. (2018) The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis. Mucosal Immunol 11:1454-1465
Delmont, Tom O; Eren, A Murat (2018) Linking pangenomes and metagenomes: the Prochlorococcus metapangenome. PeerJ 6:e4320
Feagan, Brian G; Schwartz, David; Danese, Silvio et al. (2018) Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2. J Crohns Colitis 12:621-626
Cardona, Cesar; Lax, Simon; Larsen, Peter et al. (2018) Environmental Sources of Bacteria Differentially Influence Host-Associated Microbial Dynamics. mSystems 3:
Salas Garcia, Mariana C; Yee, Alyson L; Gilbert, Jack A et al. (2018) Dysbiosis in Children Born by Caesarean Section. Ann Nutr Metab 73 Suppl 3:24-32
He, Lei; Liu, Tianjing; Shi, Yongyan et al. (2018) Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis. Endocrinology 159:967-979
Micic, Dejan; Hirsch, Ayal; Setia, Namrata et al. (2018) Enteric infections complicating ulcerative colitis. Intest Res 16:489-493

Showing the most recent 10 out of 697 publications